Clinical Trials Browser

Phase 1 × Has results × Imatinib Mesylate × Clear all

NCT01795716 2015-05-19

Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body

Phase 1 Completed

21 enrolled 5 charts

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00424385 2014-07-21

Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC)

Phase 1 Completed

17 enrolled 8 charts

Prostatic Neoplasms